557 related articles for article (PubMed ID: 9421271)
1. Cardiovascular effects of the novel Ca2+-sensitiser EMD 57033 in pigs at rest and during treadmill exercise.
Stubenitsky R; van der Weerd RW; Haitsma DB; Verdouw PD; Duncker DJ
Br J Pharmacol; 1997 Dec; 122(7):1257-70. PubMed ID: 9421271
[TBL] [Abstract][Full Text] [Related]
2. Systemic, pulmonary and coronary haemodynamic actions of the novel dopamine receptor agonist in awake pigs at rest and during treadmill exercise Z1046.
Duncker DJ; Haitsma DB; van der Geest IE; Stubenitsky R; van Meegen JR; Man in't Veld AJ; Verdouw PD
Br J Pharmacol; 1997 Mar; 120(6):1101-13. PubMed ID: 9134223
[TBL] [Abstract][Full Text] [Related]
3. Beneficial effects of the Ca2+ sensitizer EMD 57033 in exercising pigs with infarction-induced chronic left ventricular dysfunction.
Duncker DJ; Haitsma DB; Liem DA; Heins N; Stubenitsky R; Verdouw PD
Br J Pharmacol; 2001 Oct; 134(3):553-62. PubMed ID: 11588109
[TBL] [Abstract][Full Text] [Related]
4. Cardiovascular profile of the calcium sensitizer EMD 57033 in open-chest anaesthetized pigs with regionally stunned myocardium.
de Zeeuw S; Trines SA; Krams R; Verdouw PD; Duncker DJ
Br J Pharmacol; 2000 Apr; 129(7):1413-22. PubMed ID: 10742297
[TBL] [Abstract][Full Text] [Related]
5. Role of force--frequency relation during AV-block, sinus node block and beta-adrenoceptor block in conscious animals.
De Pauw M; Vilaine JP; Heyndrickx GR
Basic Res Cardiol; 2004 Sep; 99(5):360-71. PubMed ID: 15338245
[TBL] [Abstract][Full Text] [Related]
6. The cardiac effects of pimobendan (but not amrinone) are preserved at rest and during exercise in conscious dogs with pacing-induced heart failure.
Ohte N; Cheng CP; Suzuki M; Little WC
J Pharmacol Exp Ther; 1997 Jul; 282(1):23-31. PubMed ID: 9223536
[TBL] [Abstract][Full Text] [Related]
7. The inotropic and beta blocking effects of a chimeric molecule that putatively inhibits both type III phosphodiesterase and beta adrenoceptors in anesthetized dogs.
Shaffer JE; Grizzle MK; Anderson DK; Wheeler TN
J Pharmacol Exp Ther; 1993 Jun; 265(3):1105-12. PubMed ID: 8099617
[TBL] [Abstract][Full Text] [Related]
8. Effects of calcium sensitizers on intracellular calcium handling and myocardial energetics.
Hasenfuss G; Pieske B; Kretschmann B; Holubarsch C; Alpert NR; Just H
J Cardiovasc Pharmacol; 1995; 26 Suppl 1():S45-51. PubMed ID: 8907130
[TBL] [Abstract][Full Text] [Related]
9. Zatebradine, a specific bradycardic agent, alters the hemodynamic and left ventricular mechanical actions of levosimendan, a new myofilament calcium sensitizer, in conscious dogs.
Pagel PS; Harkin CP; Hettrick DA; Warltier DC
J Pharmacol Exp Ther; 1995 Oct; 275(1):127-35. PubMed ID: 7562540
[TBL] [Abstract][Full Text] [Related]
10. Regulation of coronary blood flow during exercise.
Duncker DJ; Bache RJ
Physiol Rev; 2008 Jul; 88(3):1009-86. PubMed ID: 18626066
[TBL] [Abstract][Full Text] [Related]
11. Positive chronotropic and inotropic effects of pimobendan (UD-CG 115 BS) in isolated, cross-circulated canine heart preparations.
Furukawa Y; Akahane K; Ogiwara Y; Haniuda M; Chiba S
Arch Int Pharmacodyn Ther; 1989; 300():159-73. PubMed ID: 2575887
[TBL] [Abstract][Full Text] [Related]
12. In vivo evidence of positive inotropism of EMD 57033 through calcium sensitization.
Haeusler G; Jonas R; Minck KO; Schliep HJ; Schelling P; Weygandt H; Lues I
J Cardiovasc Pharmacol; 1997 May; 29(5):647-55. PubMed ID: 9213208
[TBL] [Abstract][Full Text] [Related]
13. Effects of Ca2+ sensitizers on contraction, [Ca2+]i transient and myofilament Ca2+ sensitivity in diabetic rat myocardium: potential usefulness as inotropic agents.
Ishitani T; Hattori Y; Sakuraya F; Onozuka H; Makino T; Matsuda N; Gando S; Kemmotsu O
J Pharmacol Exp Ther; 2001 Aug; 298(2):613-22. PubMed ID: 11454923
[TBL] [Abstract][Full Text] [Related]
14. Differential alteration of cardiotonic effects of EMD 57033 and beta-adrenoceptor agonists in volume-overload rabbit ventricular myocytes.
Sugawara H; Sakurai K; Atsumi H; Nakada S; Tomoike H; Endoh M
J Card Fail; 2000 Dec; 6(4):338-49. PubMed ID: 11145759
[TBL] [Abstract][Full Text] [Related]
15. Effects of acute cardioselective and non-selective beta-adrenergic blockade on left-ventricular volumes and vascular resistance at rest and during exercise.
Kelbaek H; Godtrfedsen J
Scand J Clin Lab Invest; 1991 Apr; 51(2):161-6. PubMed ID: 1675022
[TBL] [Abstract][Full Text] [Related]
16. Cardiac electrophysiologic and hemodynamic activity of pimobendan (UD-CG 115 BS), a new inotropic agent.
Kitzen JM; Lynch JJ; Driscoll EM; Lucchesi BR
J Pharmacol Exp Ther; 1988 Mar; 244(3):929-39. PubMed ID: 3252039
[TBL] [Abstract][Full Text] [Related]
17. EMD 53998 acts as Ca(2+)-sensitizer and phosphodiesterase III-inhibitor in human myocardium.
Uhlmann R; Schwinger RH; Lues I; Erdmann E
Basic Res Cardiol; 1995; 90(5):365-71. PubMed ID: 8585857
[TBL] [Abstract][Full Text] [Related]
18. Systemic haemodynamic actions of pimobendan (UD-CG 115 BS) and its O-demethylmetabolite UD-CG 212 Cl in the conscious pig.
Duncker DJ; Hartog JM; Levinsky L; Verdouw PD
Br J Pharmacol; 1987 Jul; 91(3):609-15. PubMed ID: 3607369
[TBL] [Abstract][Full Text] [Related]
19. [Alpha-adrenergic control of coronary circulation and left ventricular function during exertion].
Heyndrickx GR; Pannier JL
Verh K Acad Geneeskd Belg; 1990; 52(3):225-91. PubMed ID: 1977244
[TBL] [Abstract][Full Text] [Related]
20. Cardiovascular profile of pimobendan, a benzimidazole-pyridazinone derivative with vasodilating and inotropic properties.
Verdouw PD; Hartog JM; Duncker DJ; Roth W; Saxena PR
Eur J Pharmacol; 1986 Jul; 126(1-2):21-30. PubMed ID: 2875884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
